Artal Group’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-400,000
Closed -$5.6M 138
2022
Q2
$5.6M Hold
400,000
0.3% 53
2022
Q1
$6.46M Hold
400,000
0.27% 68
2021
Q4
$8.56M Hold
400,000
0.23% 68
2021
Q3
$5.88M Hold
400,000
0.13% 104
2021
Q2
$7.96M Hold
400,000
0.16% 93
2021
Q1
$12M Buy
+400,000
New +$12M 0.21% 81